TLEO Taleo Corp. (MM)

Taleo Corporation (NASDAQ: TLEO), a global leader of SaaS-based Talent Management solutions, today announced that global biopharmaceutical leader UCB has chosen Taleo's Recruiting and Reporting products to improve its talent intelligence and support a global revamp of its recruitment processes.

UCB is a global biopharma company with a team of more than 8,500 employees, a strong market presence in more than 40 countries, and numerous strategic partnerships across the industry. It aspires to be the patient-centric global biopharmaceutical leader, transforming the lives of people living with severe diseases.

Due to its global scale, UCB is putting talent intelligence at the heart of its HR and recruitment function, to ensure that it can understand and unlock the potential of its global workforce. Taleo has supported UCB's recruitment function since 2006, allowing the company to have insight into candidates and new hires, and so proved to be a solid partner for the company when it switched to a global RPO model. The global capabilities of Taleo Recruiting mean that it is ideally placed to assist the outsourced function, helping UCB to source, assess, and hire the best talent on a global scale.

Meanwhile, powerful analytic tools will deliver insight from recruiting data captured throughout the hiring process, and allow UCB to create easy-to-read executive management reports that can help the company make critical business decisions.

Jason Blessing, Executive Vice President of Taleo, said, "Access to talent intelligence is essential to understanding your talent pool and new hires. When considering how best to support its expanding recruitment function, UCB looked for a solution that could meet its needs, and that would complement its existing HR software. Taleo is able to offer this, alongside an ability to analyze quality data, meaning that UCB can save money while improving quality of hire."

Ben Park, Senior Director of Shared HR Knowledge and Operations at UCB, said, "Taleo provides us with a solution for our needs and is an investment for us in an area that is key to the success of our company -- finding key talents who will bring value to our patients. They have been a partner to us since 2006, and we are pleased to extend our contract with them and deepen our talent intelligence as a result. As a part of our agreement, all personal privacy rules and registration for the system have been met."

Follow us on Twitter and Facebook.

About Taleo Taleo (NASDAQ: TLEO) helps organizations improve the performance of their business by unlocking the power of their people. Taleo is the only company to provide industry leading solutions in every category of Talent Management. Through its cloud-based platform, Taleo optimises recruiting, performance management, learning and compensation -- and integrates them all so managers have the insights they need to achieve Talent Intelligence. Customers also plug into Taleo's unique Talent Grid community to harness proven best practices, millions of candidates, and Taleo-ready partner solutions. From small and medium sized businesses to large enterprises, more than 5,000 organizations rely on Taleo every day to pursue growth, innovation and customer success.

Forward-looking Statements This press release contains forward-looking statements, including statements regarding the demand for and benefits from the use of Taleo's solutions. Any forward-looking statements contained in this press release are based upon Taleo's historical performance and its current plans, estimates and expectations and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Taleo's expectations as of the date of this press release. Subsequent events may cause these expectations to change, and Taleo disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Further information on potential factors that could affect actual results is included in Part II, Item 1A of Taleo's Quarterly Report on Form 10-Q, as filed with the SEC on November 9, 2011, and in other reports filed by Taleo with the SEC.